152 related articles for article (PubMed ID: 37756479)
1. Phoenix from the Ashes: Celebrating the 2023 North American Cystic Fibrosis Conference.
Bush A; Ramsey B; Shteinberg M; Martinez F
Am J Respir Crit Care Med; 2023 Nov; 208(9):909-910. PubMed ID: 37756479
[No Abstract] [Full Text] [Related]
2. Highlights of the 2010 North American Cystic Fibrosis Conference.
Southern KW
J R Soc Med; 2011 Jul; 104 Suppl 1(Suppl 1):S15-8. PubMed ID: 21719887
[No Abstract] [Full Text] [Related]
3. Mutation analysis for cystic fibrosis in a North American population.
Beaudet AL; Feldman GL; Kobayashi K; Lemna WK; Fernbach SD; Knowles MR; Boucher RC; O'Brien WE
Adv Exp Med Biol; 1991; 290():53-4. PubMed ID: 1950757
[No Abstract] [Full Text] [Related]
4. Highlights from the 2015 North American Cystic Fibrosis Conference.
Zemanick ET; Ong T; Daines CL; Dellon EP; Muhlebach MS; Esther CR
Pediatr Pulmonol; 2016 Jun; 51(6):650-7. PubMed ID: 27074261
[TBL] [Abstract][Full Text] [Related]
5. Highlights of the North American Cystic Fibrosis Conference 2009.
Jones AM; Helm J; Richmond R; Mason-Smith E; Brennan A
J R Soc Med; 2010 Jul; 103 Suppl 1(Suppl 1):S49-54. PubMed ID: 20573671
[No Abstract] [Full Text] [Related]
6. Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.
Flume PA; Biner RF; Downey DG; Brown C; Jain M; Fischer R; De Boeck K; Sawicki GS; Chang P; Paz-Diaz H; Rubin JL; Yang Y; Hu X; Pasta DJ; Millar SJ; Campbell D; Wang X; Ahluwalia N; Owen CA; Wainwright CE;
Lancet Respir Med; 2021 Jul; 9(7):733-746. PubMed ID: 33581080
[TBL] [Abstract][Full Text] [Related]
7. Universal community carrier screening for cystic fibrosis?
Williamson R
Nat Genet; 1993 Mar; 3(3):195-201. PubMed ID: 8485573
[TBL] [Abstract][Full Text] [Related]
8. Research agenda for pediatric gastroenterology, hepatology and nutrition: cystic fibrosis and pancreatic diseases. Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation.
Lowe ME; Ameen N; Freedman S; Mulberg AE; Werlin SL
J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 3():S258-62. PubMed ID: 12394362
[No Abstract] [Full Text] [Related]
9. Fourth annual North American and 1990 International Cystic Fibrosis Conference.
Elborn JS
Thorax; 1991 Jan; 46(1):72-3. PubMed ID: 1678555
[No Abstract] [Full Text] [Related]
10. Highlights of the 28(th) North American Cystic Fibrosis Conference 2014.
Nwokoro CE
Paediatr Respir Rev; 2015 Oct; 16 Suppl 1():12-4. PubMed ID: 26410289
[TBL] [Abstract][Full Text] [Related]
11. What did we learn from the North American Cystic Fibrosis Conference?
Bilton D
J R Soc Med; 2008 Jul; 101 Suppl 1(Suppl 1):S6-9. PubMed ID: 18607012
[No Abstract] [Full Text] [Related]
12. Highlights from the 2016 North American Cystic Fibrosis Conference.
Zemanick ET; Daines CL; Dellon EP; Esther CR; Kinghorn B; Ong T; Muhlebach MS
Pediatr Pulmonol; 2017 Aug; 52(8):1103-1110. PubMed ID: 28696526
[TBL] [Abstract][Full Text] [Related]
13. Highlights from the 2018 North American cystic fibrosis conference.
Martiniano SL; Daines CL; Dellon EP; Esther CR; Muhlebach MS; Ong T; Rabinowitz EC; Toprak D; Zemanick ET
Pediatr Pulmonol; 2019 Jul; 54(7):941-948. PubMed ID: 31091021
[TBL] [Abstract][Full Text] [Related]
14. Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.
Kerem E; Konstan MW; De Boeck K; Accurso FJ; Sermet-Gaudelus I; Wilschanski M; Elborn JS; Melotti P; Bronsveld I; Fajac I; Malfroot A; Rosenbluth DB; Walker PA; McColley SA; Knoop C; Quattrucci S; Rietschel E; Zeitlin PL; Barth J; Elfring GL; Welch EM; Branstrom A; Spiegel RJ; Peltz SW; Ajayi T; Rowe SM;
Lancet Respir Med; 2014 Jul; 2(7):539-47. PubMed ID: 24836205
[TBL] [Abstract][Full Text] [Related]
15. New insights into gene-specific management in cystic fibrosis from the 2012 European Cystic Fibrosis Conference.
Butler CA; Bell SC
Expert Rev Respir Med; 2012 Nov; 6(5):499-501. PubMed ID: 23134242
[TBL] [Abstract][Full Text] [Related]
16. Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians.
Palomaki GE; Haddow JE; Bradley LA; FitzSimmons SC
Genet Med; 2002; 4(2):90-4. PubMed ID: 11882786
[TBL] [Abstract][Full Text] [Related]
17. Highlights from the 2017 North American Cystic Fibrosis Conference.
Martiniano SL; Toprak D; Ong T; Zemanick ET; Daines CL; Muhlebach MS; Esther CR; Dellon EP
Pediatr Pulmonol; 2018 Jul; 53(7):979-986. PubMed ID: 29660839
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis in Pueblo Indian children.
Gerdes JS; Murphy S
Clin Pediatr (Phila); 1985 Feb; 24(2):104-6. PubMed ID: 3967445
[TBL] [Abstract][Full Text] [Related]
19. Nebulised hypertonic saline for cystic fibrosis.
Wark PA; McDonald V
Cochrane Database Syst Rev; 2000; (2):CD001506. PubMed ID: 10796798
[TBL] [Abstract][Full Text] [Related]
20. Understanding the population structure of North American patients with cystic fibrosis.
Li W; Sun L; Corey M; Zou F; Lee S; Cojocaru AL; Taylor C; Blackman SM; Stephenson A; Sandford AJ; Dorfman R; Drumm ML; Cutting GR; Knowles MR; Durie P; Wright FA; Strug LJ
Clin Genet; 2011 Feb; 79(2):136-46. PubMed ID: 20681990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
